Dr Hoenle AG
XETRA:HNL

Watchlist Manager
Dr Hoenle AG Logo
Dr Hoenle AG
XETRA:HNL
Watchlist
Price: 7.6 EUR 1.06% Market Closed
Market Cap: 46.1m EUR
Have any thoughts about
Dr Hoenle AG?
Write Note

Dr Hoenle AG
Investor Relations

Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. The company is headquartered in Graefelfing, Bayern and currently employs 657 full-time employees. The company went IPO on 2008-02-25. The firm develops, manufactures and supplies ultraviolet (UV) equipment. The firm operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The firm is globally active, with over 69 locations in 27 countries.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Markus Arendt
CEO, MD & Chairman of the Management Board
No Bio Available
Robert Stark
Chief Finance Officer
No Bio Available
Peter Weinert
Head of Investor Relations
No Bio Available

Contacts

Address
BAYERN
Graefelfing
Lochhamer Schlag 1
Contacts
+4989856080.0
www.hoenle.de